Procure a Safety Study for use of Polyethylene Glycol in Children
Award Notice Posted
- Solicitation number
- 75F40120C00061
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Awarded
- to The Children's Hospital Of Philadelphia
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40120C00061 Federal contract award
- NAICS code
- Not on record
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Food and Drug Administration announces the award of contract 75F40120C00061 to The Children's Hospital of Philadelphia on September 4, 2020. The $651,700 contract funds a safety study to assess whether Polyethylene Glycol metabolites can be detected in blood and urine samples collected from pediatric participants who use Polyethylene Glycol chronically for at least one month to treat constipation. The contractor must complete work initiated under a previous grant to understand if Polyethylene Glycol metabolites can be identified in blood components and urine of children using improved assay methods developed by the FDA.
Notice text
Safety Study for use of Polyethylene Glycol in Children
Awarded contract 75F40120C00061 to The Children's Hospital of Philadelphia for 651700.00 on 2020-09-04.
Files
| File | Type | Posted |
|---|---|---|
| 75F40120C00061 CB_FE.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity